This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

5 Dividend Stocks Ready to Boost Payouts

Quest Diagnostics

Quest Diagnostics (DGX - Get Report) has made big business of trivial lab diagnostics like bloodwork and drug tests. The firm's 2,000 locations make Quest one of the largest medical testing companies in the world, and the recent affirmation of healthcare reform in the U.S. could make the firm even bigger. With more patients insured, the volume of testing that Quest performs is likely to rise in kind.

A changing set of tests should increase profitability as well. The firm has been expanding its offerings to include more complex testing products (such as genetic testing and pathology testing) that have high barriers to entry for physicians' practices to replicate. As a result, testing margins on those products tend to be more profitable for Quest. While improved physician tools are a nice plus that should help make customers stickier, they're unlikely to create a material defense against peers. Instead, a rising industry tide is likely to lift all ships in the medical diagnostics field.

To be sure, Quest Diagnostics' 1.1% dividend yield hardly makes it a core income stock. But a strong balance sheet and improving profitability should lay the path for a hike to its 17-cent quarterly dividend check.

The firm's Oct. 17 earnings call looks like a good opportunity for management to give investors a raise.
5 of 6

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
EIX $72.30 -0.63%
DGX $75.51 0.69%
NUE $48.46 -0.08%
PNW $73.22 -0.69%
PCAR $55.61 -0.50%


Chart of I:DJI
DOW 17,660.71 +9.45 0.05%
S&P 500 2,050.63 -0.49 -0.02%
NASDAQ 4,717.0940 -8.5450 -0.18%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs